Jade Therapeutics
Waltham
About Jade Therapeutics
Jade Therapeutics develops ophthalmic sustained-release drug delivery platforms. The company focuses on the development of locally administered, sustained-release therapeutics that improve corneal healing following damage from disease or injury and improve visual function and quality of life. Its product delivers recombinant human growth hormone, a well-characterized biologic, that has healing properties via the activation and recruitment of key cells involved in the tissue-building process.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.1M
- Funding stage: M&A
- Last round: Grant (Nov 2014)
- Website: jadetherapeutics.com
Industries & Categories
Biotechnology, Health Care, Medical, Visual Search
Canonical: https://fsome.com/organization/jade-therapeutics-2784761 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.